Rgkl was found to treat liver cirrhosis mainly by affecting the signaling pathways such as PI3K-Akt signaling pathway, Fatty acid degradation, PPAR signaling pathway, and Vascular smooth muscle contraction. This evidence concerns the gene AKT1 and cirrhosis of liver.